These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 720077)

  • 1. Sustained intrauterine release of d-norgestrel.
    Luukkainen T; Nilsson CG
    Contraception; 1978 Oct; 18(4):451-4. PubMed ID: 720077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of plasma concentrations of d-norgestrel during a one year follow-up in women with a d-norgestrel-releasing IUD.
    Nilsson CG; Luukkainen T; Lähteenmäki P
    Contraception; 1978 Jun; 17(6):569-73. PubMed ID: 720062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-norgestrel slow-releasing T device as an intrauterine contraceptive.
    El-Mahgoub
    Am J Obstet Gynecol; 1975 Sep; 123(2):133-8. PubMed ID: 1163576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial morphology of women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Luukkainen T; Arko H
    Fertil Steril; 1978 Apr; 29(4):397-401. PubMed ID: 648644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.
    Nilsson CG; Lähteenmäki P; Robertson DN; Luukkainen T
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):380-4. PubMed ID: 7376797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained intrauterine release of levonorgestrel over five years.
    Nilsson CG; Lahteenmaki PL; Luukkainen T; Robertson DN
    Fertil Steril; 1986 Jun; 45(6):805-7. PubMed ID: 3086130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki P
    Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of a d-norgestrel-releasing IUD.
    Nilsson CG
    Contraception; 1977 Mar; 15(3):295-306. PubMed ID: 880809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A D-norgestrel-releasing IUD.
    Nilsson CG; Johansson ED; Luukkainen T
    Contraception; 1976 Apr; 13(4):503-14. PubMed ID: 1253602
    [No Abstract]   [Full Text] [Related]  

  • 10. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
    Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
    Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device.
    Nilsson CG
    Contraception; 1977 Apr; 15(4):379-87. PubMed ID: 880815
    [No Abstract]   [Full Text] [Related]  

  • 12. Recovery of ovarian function after the use of a d-norgestrel-releasing IUD.
    Nilsson CG; Lähteenmäki P
    Contraception; 1977 Apr; 15(4):389-400. PubMed ID: 328225
    [No Abstract]   [Full Text] [Related]  

  • 13. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
    Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
    Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
    Moore DE; Roy S; Stanczyk FZ; Mishell DR
    Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
    Toivonen J; Luukkainen T; Allonen H
    Obstet Gynecol; 1991 Feb; 77(2):261-4. PubMed ID: 1899136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of norplant-2 and levonorgestrel-releasing intrauterine devices].
    Wang SL
    Zhonghua Fu Chan Ke Za Zhi; 1990 Jul; 25(4):232-4, 253. PubMed ID: 2119982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids and high-density-lipoprotein cholesterol in women on long-term sustained low-dose IUD treatment with levonorgestrel.
    Nilsson CG; Kostiainen E; Ehnholm C
    Int J Fertil; 1981; 26(2):135-7. PubMed ID: 6114067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdose intrauterine levonorgestrel for contraception. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation.
    Contraception; 1987 Apr; 35(4):363-79. PubMed ID: 2887401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.